Oestrogen confers cardioprotection by suppressing Ca 2+/ calmodulin-dependent protein kinase II

British Journal of Pharmacology

Volumn 157, Issue 5, 2009, Pages 705-715

  Ma, Y ^a   Cheng, W T ^a   Wu, S ^a   Wong, T M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

adrenoceptor; Apoptosis; CaMKII; Oestrogen; Ovariectomy

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; ESTROGEN; ISOPRENALINE; LACTATE DEHYDROGENASE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; BENZYLAMINES; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG IMPLANTS; ESTROGENS; FEMALE; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OVARIECTOMY; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECOVERY OF FUNCTION; SULFONAMIDES;

EID: 70350145171     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00212.x     Document Type: Article

References (43)

1. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415: 198-205.
2. Braun AP, Schulman H (1995). The multifunctional calcium/ calmodulin-dependent protein kinase-from form to function. Annu Rev Physiol 57: 417-445.
3. Campbell DL, Strauss HC (1995). Regulation of calcium channels in the heart. Adv Second Messenger Phosphoprotein Res 30: 25-88.
4. Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW (2006). Effect of estrogen on calcium-handling proteins, beta-adrenergic receptors, and function in rat heart. Life Sci 79: 1257-1267. (Pubitemid 44188794)
5. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH (1987). Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105-1110. (Pubitemid 17052498)
6. Communal C, Singh K, Sawyer DB, Colucci WS (1999). Opposing effects of beta(l)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100: 2210-2212.
7. 2+ exchanger increases susceptibility to Ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83: 1215-1223.
8. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ (1991). Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60: 653-688.
9. Hayward CS, Kelly RP, Collins P (2000). The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46: 28-49. (Pubitemid 30155943)
10. 2+/CaM-dependent kinases: from activation to function. Annu Rev Pharmacol Toxicol 41: 471-505.
11. Hsieh YC, Yu HP, Suzuki T, Choudhry MA, Schwacha MG, Bland KI et al. (2006). Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Celt Cardiol 41: 511-521. (Pubitemid 44344281)
12. Hu A, Jiao X, Gao E, Koch WJ, Sharifi-Azad S, Grunwald Z et al. (2006). Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischaemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J Pharmacol Exp Ther 318: 469-475.
13. Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM (1997). Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol 110:135-140. (Pubitemid 27340485)
14. 2+ loading. J Am Coll Cardiol 36: 948-952.
15. Kam KW, Qi JS, Chen M, Wong TM (2004). Estrogen reduces cardiac injury and expression of beta 1-adrenoceptor upon ischaemic insult in the rat heart. J Pharmacol Exp Ther 309: 8-15.
16. 2+ channels in the heart from ovariectomized rats. Br J Pharmacol 144: 972-981.
17. Kitazawa T, Hamada E, Kltazawa K, Gaznabi AK (1997). Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J Physiol 499: 497-511. (Pubitemid 27129430)
18. 2+ exchange in the heart from ovariectomized rats: role of protein kinase A. Am J Physiol Cell Physiol 292: C1625-C1635.
19. Li L, Zhang LK, Pang YZ, Pan CS, Qi YF, Chen L et al. (2006). Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin 27: 527-535.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275.
21. Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C, Murphy E (2007). Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 42: 769-780. (Pubitemid 46527602)
22. Otani H, Matsuhlsa S, Akita Y, Kyol S, Enoki C, Tatsumi K et al. (2006). Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion. Cire f 70: 1344-1355. (Pubitemid 44453232)
23. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X et al. (2004). 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95: 692-699. (Pubitemid 39331929)
24. Patterson E, Ma L, Szabo B, Robinson CP, Thadani U (1998). Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther 284: 586-591. (Pubitemid 28086645)
25. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. I Biol Chem 272: 31203-31208.
26. 2-/ calmodulin-dependent protein kinase II gamma-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes. J Biol Chem 272: 9393-9400.
27. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE et al. (1991). Postmenopausal Estrogen Therapy and Cardiovascular-Disease - 10-Year Follow-up from the Nurses' Health Study. N Engl J Med 325: 756-762.
28. Thawomkaiwong A, Preawnim S, Wattanapermpool J (2003). Upregulation of beta 1-adrenergic receptors in ovariectomized rat hearts. Life Sci 72: 1813-1824. (Pubitemid 36174019)
29. Tobimatsu T, Fujisawa H (1989). Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem 264: 17907-17912. (Pubitemid 19279256)
30. 2+ channel Cavl.2. Biochem Biophys Res Commun 361: 522-527.
31. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E et al. (2007). CaMKII inhibition protects against necrosis and apoptosis in irreversible ischaemia-reperfusion injury. Cardiovasc Res 73: 689-698. (Pubitemid 46227351)
32. Vittone L, Mundina-Weilenmann C, Said M, Ferrero P, Mattiazzi A (2002). Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways. J Mol Cell Cardiol 34: 39-50. (Pubitemid 34146394)
33. Wang GY, Wu S, Pel JM, Yu XC, Wong TM (2001). Kappa- but not delta-opioid receptors mediate effects of ischaemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 280: H384-H391. (Pubitemid 32493120)
34. 2+/calmoduIin kinase signaling pathway. Circ Res 95: 798-806.
35. Wilson PW, Garrison RJ, Castelli WP (1985). Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 313: 1038-1343.
36. Wu S, Li HY, Wong TM (1999). Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84: 1388-1395. (Pubitemid 29293216)
37. Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatto EG et al. (2006). Subtype-specific alphal- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 6: 330-337.
38. Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC et al. (2008). Insulin inhibits beta-adrenergic action in ischaemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Apoptosis 13: 305-317.
39. Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA (2000). Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102: 344-350. (Pubitemid 30457587)
40. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G et al. (2005). Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11: 409-417. (Pubitemid 40562331)
41. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovase Res 63: 476-486.
42. 2+/ calmodulin kinase II. J Clin Invest 111: 617-625.
43. Zhu WZ, Woo AYH, Yang DM, Cheng HP, Crow MT, Xiao RP (2007). Activation of CaMKII delta C is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 282: 10833-10839.